KOP Q1 2026 Earnings EPS Soars 297 Above Estimates Driving Positive Market Reaction ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat PLBY Q1 2026 Earnings EPS Misses Estimates Amidst Ongoing Challenges PSEC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline FINV Q4 2025 Earnings Earnings Per Share Reported at 1722925 Amid Market Headwinds